Authors:
HIDALGO M
RODRIGUEZ G
KUHN JG
BROWN T
WEISS G
MACGOVREN JP
VONHOFF DD
ROWINSKY EK
Citation: M. Hidalgo et al., A PHASE-I AND PHARMACOLOGICAL STUDY OF THE GLUTAMINE ANTAGONIST ACIVICIN WITH THE AMINO-ACID SOLUTION AMINOSYN IN PATIENTS WITH ADVANCED SOLID MALIGNANCIES, Clinical cancer research, 4(11), 1998, pp. 2763-2770
Authors:
CASTELLANO D
LIANES P
PAZARES L
HIDALGO M
GUERRA JA
GOMEZMARTIN C
GOMEZ H
CALZAS J
CORTESFUNES H
Citation: D. Castellano et al., A PHASE-II STUDY OF A NOVEL GEMCITABINE PLUS CISPLATIN REGIMEN ADMINISTERED EVERY 3 WEEKS FOR ADVANCED NON-SMALL-CELL LUNG-CANCER, Annals of oncology, 9(4), 1998, pp. 457-459
Authors:
HIDALGO M
VILLALONACALERO MA
ECKHARDT SG
WEISS G
CAMPBELL E
KRAYNAK M
BEIJNEN J
JIMENO J
VONHOFF D
ROWINSKY E
Citation: M. Hidalgo et al., A PHASE-I AND PHARMACOKINETIC (PK) STUDY OF ET-743, A NOVEL MINOR-GROOVE BINDER OF MARINE ORIGIN ADMINISTERED ON A DAILY X 5 SCHEDULE, Annals of oncology, 9, 1998, pp. 613-613
Authors:
HAMMOND L
VILLALONACALERO M
ECKHARDT SG
SIU L
HIDALGO M
THORNTON D
WALLING J
BAKER S
COLTMAN C
VONHOFF D
ROWINSKY E
Citation: L. Hammond et al., A PHASE-I AND PHARMACOKINETIC (PK) STUDY OF THE MULTITARGETED ANTIFOLATE (MTA, LY231514) WITH FOLIC-ACID (FA), Annals of oncology, 9, 1998, pp. 620-620
Authors:
BRITTEN CD
DIAB S
HIDALGO M
YOUNG R
BAKER S
RAZVILLAS B
AVERBUCH S
SMITH M
VONHOFF DD
ROWINSKY EK
Citation: Cd. Britten et al., A PHASE-I AND PHARMACOKINETIC (PK) STUDY OF ZD9331, A NONPOLYGLUTAMINATED THYMIDYLATE SYNTHASE (TS) INHIBITOR, ADMINISTERED ONCE EVERY 3 WEEKS, Annals of oncology, 9, 1998, pp. 622-622
Authors:
VILLALONACALERO M
ECKHARDT SG
WEISS G
CAMPBELL E
HIDALGO M
KRAYNAK M
BEIJNEN J
JIMENO J
VONHOFF D
ROWINSKY E
Citation: M. Villalonacalero et al., A PHASE-I AND PHARMACOKINETIC STUDY OF ET-743, A NOVEL DNA MINOR-GROOVE BINDER OF MARINE ORIGIN, ADMINISTERED AS A 1-HOUR INFUSION DAILY X 5 DAYS, Annals of oncology, 9, 1998, pp. 453-453
Authors:
ECKHARDT SG
THURMAN A
KRAYNAK M
HIDALGO M
HANHAM A
VONHOFF DD
ROWINSKY EK
Citation: Sg. Eckhardt et al., A PHASE-I AND PHARMACOLOGICAL (PK) STUDY OF VESNARINONE, AN INDUCER OF DIFFERENTIATION AND APOPTOSIS, IN COMBINATION WITH GEMCITABINE, Annals of oncology, 9, 1998, pp. 478-478
Authors:
DIAB S
BRITTEN C
SMITH R
ECKHARDT SG
BAKER S
HAMMOND L
SIU L
SHARMA S
HIDALGO M
AYLESWORTH C
YOUNG R
WONG L
RAZVILLAS B
KRAYNAK M
DOUGLASS E
VONHOFF D
ROWINSKY E
Citation: S. Diab et al., A PHASE-I AND PHARMACOKINETIC (PK) STUDY OF ZD9331, A NOVEL LONG-ACTING THYMIDYLATE SYNTHETASE (TS) INHIBITOR, ON A SINGLE DOSING EVERY 3 WEEKS SCHEDULE, Annals of oncology, 9, 1998, pp. 611-611
Authors:
HAMMOND L
BAKER SD
VILLALONACALERO M
ECKHARDT SG
DRENGLER R
AYLESWORTH C
JOHNSON T
HIDALGO M
RODRIGUEZ G
DIAB S
MONROE P
THORNTON D
JOHNSON R
VONHOFF D
ROWINSKY E
Citation: L. Hammond et al., A PHASE-I AND PHARMACOKINETIC (PK) STUDY OF THE MULTITARGETED ANTIFOL(MTA) LY231514 WITH FOLIC-ACID (FA), Annals of oncology, 9, 1998, pp. 612-612
Authors:
HIDALGO M
VILLALONACALERO MA
BRITTEN C
SIU L
DRENGLER R
HAMMOND L
DIAB S
CAMPBELL E
LOUIE A
ONEIL J
VONHOFF D
ROWINSKY E
Citation: M. Hidalgo et al., A PHASE-I AND PHARMACOKINETIC (PK) STUDY OF PN401 AS A RESCUE AGENT FOR ESCALATING DOSES OF 5-FLUOROURACIL (5-FU) IN PATIENTS WITH CANCER, Annals of oncology, 9, 1998, pp. 625-625
Authors:
GOMEZ H
HIDALGO M
CASANOVA L
COLOMER R
PEN DLK
OTERO J
RODRIGUEZ W
CARRACEDO C
CORTESFUNES H
VALLEJOS C
Citation: H. Gomez et al., RISK-FACTORS FOR TREATMENT-RELATED DEATH IN ELDERLY PATIENTS WITH AGGRESSIVE NON-HODGKINS-LYMPHOMA - RESULTS OF A MULTIVARIATE-ANALYSIS, Journal of clinical oncology, 16(6), 1998, pp. 2065-2069
Authors:
HIDALGO M
BELTRAN MI
REINECKE H
MIJANGOS C
Citation: M. Hidalgo et al., THERMAL AND MECHANICAL-PROPERTIES OF SILANE-CROSS-LINKED POLY(VINYLCHLORIDE), Journal of applied polymer science, 70(5), 1998, pp. 865-872
Authors:
HIDALGO M
MENDIOLA C
LOPEZVEGA JM
CASTELLANO D
MENDEZ M
BATISTEALENTON E
LOPEZBREA M
BELON J
BATISTA JN
CORTESFUNES H
Citation: M. Hidalgo et al., A MULTICENTER RANDOMIZED PHASE-II TRIAL OF GRANULOCYTE-COLONY-STIMULATING FACTOR-SUPPORTED, PLATINUM-BASED CHEMOTHERAPY WITH FLEXIBLE MIDCYCLE CISPLATIN ADMINISTRATION IN PATIENTS WITH ADVANCED OVARIAN-CARCINOMA, Cancer, 83(4), 1998, pp. 719-725
Authors:
HIDALGO M
PAZARES L
RIVERA F
LIANES P
HUIDOBRO G
RUIZ A
LOPEZBREA M
SANZORTIZ J
LOPEZ JL
CORTESFUNES H
TABERNERO JM
Citation: M. Hidalgo et al., MEDIASTINAL NONSEMINOMATOUS GERM-CELL TUMORS (MNSGCT) TREATED WITH CISPLATIN-BASED COMBINATION CHEMOTHERAPY, Annals of oncology, 8(6), 1997, pp. 555-559
Authors:
GARCIACARBONERO R
HIDALGO M
PAZARES L
CALZAS J
GOMEZ H
GUERRA JA
HITT R
HORNEDO J
COLOMER R
CORTESFUNES H
Citation: R. Garciacarbonero et al., PATIENT SELECTION IN HIGH-DOSE CHEMOTHERAPY TRIALS - RELEVANCE IN HIGH-RISK BREAST-CANCER, Journal of clinical oncology, 15(10), 1997, pp. 3178-3184
Authors:
CHEVALIER Y
HIDALGO M
CAVAILLE JY
CABANE B
Citation: Y. Chevalier et al., SMALL-ANGLE NEUTRON-SCATTERING STUDIES OF COMPOSITE LATEX FILM STRUCTURE, Progress in organic coatings, 32(1-4), 1997, pp. 35-41
Authors:
WASSERMAN E
HIDALGO M
HORNEDO J
CORTESFUNES H
Citation: E. Wasserman et al., OCTREOTIDE (SMS 201-995) FOR HEMATOPOIETIC SUPPORT-DEPENDENT HIGH-DOSE CHEMOTHERAPY (HSD-HDC)-RELATED DIARRHEA - DOSE-FINDING STUDY AND EVALUATION OF EFFICACY, Bone marrow transplantation, 20(9), 1997, pp. 711-714
Authors:
HITT R
PAZARES L
HIDALGO M
COLOMER R
BRANDARIZ A
PENA M
ALVAREZVICENT J
HORNEDO J
CORTESFUNES H
Citation: R. Hitt et al., PHASE-I PHASE-II STUDY OF PACLITAXEL CISPLATIN AS FIRST-LINE THERAPY FOR LOCALLY ADVANCED HEAD AND NECK-CANCER/, Seminars in oncology, 24(6), 1997, pp. 20-24
Authors:
HITT R
HORNEDO J
COLOMER R
HIDALGO M
BRANDARIZ A
PENA M
VICENT JA
CORTESFUNES H
Citation: R. Hitt et al., STUDY OF ESCALATING DOSES OF PACLITAXEL PLUS CISPLATIN IN PATIENTS WITH INOPERABLE HEAD AND NECK-CANCER, Seminars in oncology, 24(1), 1997, pp. 58-64
Authors:
HIDALGO M
HORNEDO J
LUMBRERAS C
TRIGO JM
GOMEZ C
PEREA S
RUIZ A
HITT R
CORTESFUNES H
Citation: M. Hidalgo et al., LACK OF ABILITY OF CIPROFLOXACIN-RIFAMPIN PROPHYLAXIS TO DECREASE INFECTION-RELATED MORBIDITY IN NEUTROPENIC PATIENTS GIVEN CYTOTOXIC THERAPY AND PERIPHERAL-BLOOD STEM-CELL TRANSPLANTS, Antimicrobial agents and chemotherapy, 41(5), 1997, pp. 1175-1177
Citation: M. Hidalgo, SPANISH IN 4 CONTINENTS - STUDIES IN LANGUAGE CONTACT AND BILINGUALISM - SILVACORVALAN,C, Language in society, 26(3), 1997, pp. 453-456
Citation: M. Hidalgo, EXPOSING PREJUDICE - PUERTO-RICAN EXPERIENCES OF LANGUAGE, RACE, AND CLASS - URCIUOLI,B, Anthropological quarterly, 70(4), 1997, pp. 199-200
Authors:
OMENETTO N
CAVALLI P
HIDALGO M
PETRUCCI GA
Citation: N. Omenetto et al., LASER-INDUCED PHOTOFRAGMENTATION AND FLUORESCENCE SPECTROSCOPY - TOOLS FOR STUDYING ATMOSPHERIC CHEMICAL-REACTIONS AND AEROSOLS, Annali di chimica, 87(3-4), 1997, pp. 241-253
Authors:
FONTAS C
ANTICO E
SALVADO V
VALIENTE M
HIDALGO M
Citation: C. Fontas et al., CHEMICAL PUMPING OF RHODIUM BY A SUPPORTED LIQUID MEMBRANE CONTAININGALIQUAT 336 AS CARRIER, Analytica chimica acta, 346(2), 1997, pp. 199-206